Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X842 vs Lansoprazole in Erosive Esophagitis
NCT05055128Phase 2Completed
- Sponsor
- Cinclus Pharma
- Start
- Aug 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of linaprazan glurate in erosive esophagitis (EE), sponsored by Cinclus Pharma. Started Aug 2021; status: completed.
02
Drugs
linaprazan glurate
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT05055128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05055128.